Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm.

OBJECTIVE Accurate information about the magnitude and distribution of diabetes can inform policy and support health care evaluation. We linked physician service claims (PSCs) and hospital discharge abstracts (HDAs) to determine diabetes prevalence and incidence. RESEARCH DESIGN AND METHODS A retrospective cohort was constructed using administrative data from the national HDA database, PSCs for Ontario (population 11 million), and registries carrying demographics and vital statistics. All HDAs and PSCs bearing a diagnosis of diabetes (ICD9-CM 250) were selected for 1991-1999. Two previously reported algorithms for identification of diabetes were applied as follows: "1-claim" (any HDA or PSC showing diabetes) and "2-claim" (one HDA or two PSCs within 2 years showing diabetes). Incident cases were defined as individuals who met the criteria for diabetes for the first time after at least 2 years of observation. For validation, diagnostic data abstracted from primary care charts (n=3,317) of 57 randomly selected physicians were linked to the administrative data cohort, and sensitivity and specificity were calculated. RESULTS -In 1998, 696,938 individuals met the 1-claim criteria and 528,280 met the 2-claim criteria. Sensitivity for diabetes was 90 and 86%; for the 1- and 2-claim algorithms, specificity was 92 and 97%, respectively, and positive predictive values were 61 and 80%, respectively. Using the 2-claim algorithm, the all-age prevalence increased from 3.2% in 1993 to 4.5% in 1998 (6.1% in adults). Incidence remained stable. CONCLUSIONS Administrative data can be used to establish population-based incidence and prevalence of diabetes. Diabetes prevalence is increasing in Ontario and is considerably higher than self-reported rates.

[1]  H. A. Kahn,et al.  Statistics on Blindness in the Model Reporting Area 1969-1970. , 1973 .

[2]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[3]  T. K. Young,et al.  Type 2 diabetes mellitus in Canada's first nations: status of an epidemic in progress. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[4]  K. T. Chen,et al.  Epidemiology of Diabetes Mellitus , 1992 .

[5]  P C O'Brien,et al.  Relative contributions of incidence and survival to increasing prevalence of adult-onset diabetes mellitus: a population-based study. , 1997, American journal of epidemiology.

[6]  B. Penninx,et al.  Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinants of inaccuracy. , 1996, Journal of clinical epidemiology.

[7]  T. K. Young,et al.  The health of Canadians with diabetes. , 1997, Health reports.

[8]  D. Maclean,et al.  Epidemiology of diabetes mellitus in Canada. , 1995, Clinical and investigative medicine. Medecine clinique et experimentale.

[9]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[10]  N. Calonge,et al.  Validation of self-reported chronic conditions and health services in a managed care population. , 2000, American journal of preventive medicine.

[11]  M. Harris,et al.  Prevalence of Adult-Onset IDDM in the U.S. Population , 1994, Diabetes Care.

[12]  J. Mackenbach,et al.  Differences in the misreporting of chronic conditions, by level of education: the effect on inequalities in prevalence rates. , 1996, American journal of public health.

[13]  B. Yawn,et al.  Identifying Persons with Diabetes Using Medicare Claims Data , 1999, American journal of medical quality : the official journal of the American College of Medical Quality.

[14]  J. Brosseau,et al.  Geographic Differences in the Risk of Insulin-dependent Diabetes Mellitus: The Importance of Registries , 1985, Diabetes Care.

[15]  A. Wajda,et al.  Incidence and Prevalence of Diabetes in Manitoba, 1986–1991 , 1996, Diabetes Care.

[16]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[17]  R. Holman,et al.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.

[18]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[19]  L S Geiss,et al.  Prevalence of diabetes among Native Americans and Alaska Natives, 1990-1997: an increasing burden. , 2000, Diabetes care.

[20]  G. Maskarinec Diabetes in Hawaii: estimating prevalence from insurance claims data. , 1997, American journal of public health.

[21]  M. Lishner,et al.  Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. , 1996, Archives of internal medicine.